Role of Ferroptosis in Fibrotic Diseases

Role of Ferroptosis in Fibrotic Diseases

Jian Zhou, Yuan Tan, Rurong Wang, Xuehan Li Department of Anesthesiology, Laboratory of Anesthesia and Critical Care Medicine, West China Hospital, Sichuan University, Chengdu, Sichuan Province, People’s Republic of ChinaCorrespondence: Xuehan Li, Department of Anesthesiology, Laboratory of Anesthes...

Full description

Bibliographic Details
Main Authors:	Zhou J, Tan Y, Wang R, Li X
Format:	Article
Language:	English
Published:	Dove Medical Press 2022-06-01
Series:	Journal of Inflammation Research
Subjects:	ferroptosis liver fibrosis kidney fibrosis myocardial fibrosis pulmonary fibrosis
Online Access:	https://www.dovepress.com/role-of-ferroptosis-in-fibrotic-diseases-peer-reviewed-fulltext-article-JIR

Similar Items

Human Epididymis Protein 4 (HE4) as a promising biomarker and therapy target in fibrotic diseases: A review
by: Huiqun Tian, et al.
Published: (2024-12-01)

Is the Macrophage Phenotype Determinant for Fibrosis Development?
by: Lluis Lis-López, et al.
Published: (2021-11-01)

The emerging role of ferroptosis in myocardial fibrosis of atrial fibrillation
by: Honghua Yue, et al.
Published: (2023-02-01)

m6A Ribonucleic Acid Methylation in Fibrotic Diseases of Visceral Organs
by: Xiaoniu Dai, et al.
Published: (2025-02-01)

MicroRNA in Fibrotic Disorders: A Potential Target for Future Therapeutics
by: Aanushka Mehjabin, et al.
Published: (2023-11-01)

SOX9: a key transcriptional regulator in organ fibrosis
by: Yishuo Li, et al.
Published: (2025-02-01)

Histone Deacetylase (HDAC) Inhibitors as a Novel Therapeutic Option Against Fibrotic and Inflammatory Diseases
by: Maria A. Theodoropoulou, et al.
Published: (2024-12-01)

Progress of researches on inducing hepatic stellate cell ferroptosis for treatment of liver fibrosis
by: SUN Lijie, HAO Dandan
Published: (2024-01-01)

Naringenin alleviates liver ﬁbrosis by triggering autophagy-dependent ferroptosis in hepatic stellate cells
by: Ting Yu, et al.
Published: (2024-04-01)

Myocardial ferroptosis may exacerbate the progression of atrial fibrillation through isolevuglandins
by: Zhi-Jie Yue, et al.
Published: (2025-02-01)

Pharmacological modulation of ferroptosis as a therapeutic target for liver fibrosis
by: Le Li, et al.
Published: (2023-01-01)

Copper homeostasis in chronic kidney disease and its crosstalk with ferroptosis
by: Huang Jiayi, et al.
Published: (2024-04-01)

Nobiletin Alleviates Ferroptosis-Associated Renal Injury, Inflammation, and Fibrosis in a Unilateral Ureteral Obstruction Mouse Model
by: Yi-Hsin Lo, et al.
Published: (2022-03-01)

Anti-fibrotic efficacy of nintedanib in pulmonary fibrosis via the inhibition of fibrocyte activity
by: Seidai Sato, et al.
Published: (2017-09-01)

Diagnostic value of serum markers of fibrosis in chronic liver diseases
by: E V Vinnitskaia, et al.
Published: (2013-02-01)

Pulmonary Fibrosis and Progressive Pulmonary Fibrosis in a Prospective Registry of Interstitial Lung Diseases in Eastern Siberia
by: Maria S. Nashatyreva, et al.
Published: (2023-01-01)

The role of ferroptosis-related non-coding RNA in liver fibrosis
by: Guozhu Zhang, et al.
Published: (2024-12-01)

Inhibition of ferroptosis and iron accumulation alleviates pulmonary fibrosis in a bleomycin model
by: Zhuo Pei, et al.
Published: (2022-11-01)

FUNDC1 interacts with GPx4 to govern hepatic ferroptosis and fibrotic injury through a mitophagy-dependent manner
by: Yaguang Bi, et al.
Published: (2024-01-01)

Ferritinophagy: multifaceted roles and potential therapeutic strategies in liver diseases
by: Kejia Wu, et al.
Published: (2025-02-01)

Recent progress in the effect of ferroptosis of HSCs on the development of liver fibrosis
by: Rui Tang, et al.
Published: (2023-09-01)

Inhibition of Indoxyl Sulfate-Induced Reactive Oxygen Species-Related Ferroptosis Alleviates Renal Cell Injury In Vitro and Chronic Kidney Disease Progression In Vivo
by: Li-Ting Tsai, et al.
Published: (2023-10-01)

Fibroblast activation protein is a cellular marker of fibrotic activity in canine idiopathic pulmonary fibrosis
by: Elodie Rizzoli, et al.
Published: (2024-07-01)

qFibrosis: A fully-quantitative innovative method incorporating histological features to facilitate accurate fibrosis scoring in animal model and chronic hepatitis B patients
by: Xu, Shuoyu, et al.
Published: (2016)

Criteria for progressive fibrotic hypersensitivity pneumonitis in a Portuguese patient cohort
by: E Seixas, et al.
Published: (2022-12-01)

Macrophage polarization in tissue fibrosis
by: Huidan Yang, et al.
Published: (2023-10-01)

Machine Learning and Experimental Validation Identified Ferroptosis Signature and Innovative Biomarkers (ESR1 and GSTZ1) in Liver Fibrosis
by: Luo W, et al.
Published: (2024-12-01)

Pro-Fibrotic Macrophage Subtypes: SPP1+ Macrophages as a Key Player and Therapeutic Target in Cardiac Fibrosis?
by: Moritz Uhlig, et al.
Published: (2025-02-01)

Development and evaluation of a questionnaire to capture environmental and occupational inhalational exposures in adults with fibrotic interstitial lung disease
by: Aparna C Swaminathan, et al.
Published: (2024-10-01)

Idiopathic pulmonary fibrosis: current diagnosis and treatment
by: Alexandre Franco Amaral, et al.
Published: (2023-08-01)

Dihydroquercetin Attenuates Silica-Induced Pulmonary Fibrosis by Inhibiting Ferroptosis Signaling Pathway
by: Leyong Yuan, et al.
Published: (2022-05-01)

Factors associated with listing for lung transplantation in IPF patients: An analysis of the pulmonary fibrosis foundation registry
by: Christopher S. King, et al.
Published: (2023-08-01)

Genetic Deletion of Polo-Like Kinase 2 Induces a Pro-Fibrotic Pulmonary Phenotype
by: Theresa A. Kant, et al.
Published: (2021-03-01)

The Role of γδ T Cells in Fibrotic Diseases
by: Ilan Bank
Published: (2016-10-01)

Association between proteomic biomarkers and myocardial fibrosis measured by MRI: the multi-ethnic study of atherosclerosisResearch in context
by: Hooman Bakhshi, et al.
Published: (2023-04-01)

Comparison of the Results of Modeling Pulmonary Fibrosis in Sprague Dawley Rats by Intratracheal Administration of Bleomycin in the Form of Sulfate and Chloride at a Dose of 3 mg/kg
by: Elena A. Tukhovskaya, et al.
Published: (2024-10-01)

Idiopathic pulmonary fibrosis - a disorder of alveolar wound repair?
by: Swiss Medical Weekly
Published: (2003-07-01)

Ferroptosis in Chronic Liver Diseases: Opportunities and Challenges
by: Xiaoxi Zhou, et al.
Published: (2022-06-01)

Evaluation of progressive pulmonary fibrosis in non-idiopathic pulmonary fibrosis-interstitial lung diseases: a cross-sectional study
by: Özlem Erçen Diken, et al.
Published: (2024-08-01)

Pirfenidone use in fibrotic diseases: What do we know so far?
by: Aldo Torre, et al.
Published: (2024-07-01)